Acyclic cyanamide-based inhibitors of cathepsin K.
Barrett, D.G., Deaton, D.N., Hassell, A.M., McFadyen, R.B., Miller, A.B., Miller, L.R., Payne, J.A., Shewchuk, L.M., Willard, D.H., Wright, L.L.(2005) Bioorg Med Chem Lett 15: 3039-3043
- PubMed: 15896958 
- DOI: https://doi.org/10.1016/j.bmcl.2005.04.032
- Primary Citation of Related Structures:  
1YK8 - PubMed Abstract: 
Conversion of the proline-derived cyanamide lead to an acyclic cyanamide capable of forming an additional hydrogen bond with cathepsin K resulted in a large increase in inhibitory activity. An X-ray structure of a co-crystal of a cyanamide with cathepsin K confirmed the enzyme interaction. Furthermore, a representative acyclic cyanamide inhibitor 6r was able to attenuate bone resorption in the rat calvarial model.
Organizational Affiliation: 
Department of Medicinal Chemistry, GlaxoSmithKline, Research Triangle Park, NC 27709, USA.